McCarter continues IP practice growth with the addition of Isacson in Washington, DC, office.
McCarter & English, LLP, is pleased to announce that John P. Isacson has joined the firm’s Intellectual Property practice in Washington, DC, as a partner. Isacson focuses on representing clients in the pharmaceutical, biotechnology, chemical, and medical device industries in patents and patent-related regulatory matters. His clients include internationally recognized research and health care institutions, emerging ventures, investors, and large public corporations.
Jonathan Sparks, PhD, chair of McCarter & English’s Intellectual Property group, said, “We’re thrilled to have John join our team. His experience and client base, combined with his deep understanding of several key industries, fit perfectly with our client base of national and global innovator companies. Being on the ground in DC with John’s significant regulatory knowledge will extend the service offerings we provide our clients.”
“McCarter’s strategic range of practices, beyond IP, and their footprint align perfectly with my practice of protecting the intellectual property assets of innovator companies and maximizing the value of their inventions throughout their life cycle,” said Isacson.
A registered patent attorney, Isacson is a strategic counselor to his clients on all aspects of patent portfolio management. He advises on related regulatory issues with the FDA. He’s also involved in infringement litigation, due diligence, inventorship and ownership disputes, and US Patent and Trademark Office proceedings.
In his pro bono practice, Isacson counsels military veterans through his work with the National Veterans Legal Services Program, an organization that helps veterans obtain disability benefits.
Isacson graduated with honors from the George Washington University School of Law. He received an M.S. in molecular biology and a B.A. in microbiology and scientific ethics from the University of Maryland.
Prior to joining McCarter & English, Isacson was a partner with Troutman Pepper in Washington, DC.
About McCarter & English, LLP, IP Practice
McCarter’s intellectual property professionals are as experienced and innovative when it comes to the development of strategies for protecting critical core technologies as they are in patenting new innovations. With more than 100 IP professionals, including close to 30 PhDs, the group serves all facets of intellectual property development, maintenance, enforcement, regulation, and transactions. Our firm clients include some of the biggest names in the biotechnology, pharmaceutical, and technology fields, for whom we are building and managing complex patent portfolios, protecting blockbuster biotech and small-molecule drugs, and developing global strategic plans. For more information, visit www.mccarter.com.
About McCarter & English, LLP McCarter & English delivers innovative solutions to clients nationwide. Fortune 100, mid-market and emerging growth companies rely on McCarter to handle their cutting-edge transactional, intellectual property, and complex litigation advice. Clients benefit from the firm’s relationship-driven approach, deep understanding of their businesses and legal needs, lean and efficient service model, and determination to help them move their businesses forward. In 2020, McCarter was recognized as Law Firm of the Year by the New Jersey Law Journal, and in 2019 received the prestigious ABA Pro Bono Publico award. For more information, visit www.mccarter.com.